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Abstract
BACKGROUND & AIMS: The fecal immunochemical test (FIT) is an alternative to colonoscopy 
and can increase overall screening for colorectal cancer (CRC). However, little is known about the 
frequency of and reasons for mishandled FIT samples.
METHODS: We performed a prospective study, nested within a randomized controlled trial of 
patients, recruited from December 2015 through August 2017, who were not up to date with 
colorectal cancer screening (50–75 years old). The patients were randomly assigned to usual care 
or outreach groups that received a mailed FIT with low literacy level instructions or a reminder 
call, or both. We examined frequency of and reasons for mishandled FIT samples, including 
absence of collection date; time from collection to laboratory receipt of more than 14 days; or 
mishandling of stool, buffer, or cap. The outcomes were the frequency of mishandled FIT samples, 
effects of outreach on mishandling, and positive results from the FIT among proper and 
mishandled samples.
RESULTS: FIT samples were returned from 1871 patients assigned to usual care and 3045 who 
received the low literacy level instructions and a reminder call. In total, 19.8% of samples were 
mishandled; most of these (93.7%) had not labeled the date of stool collection but were still 
processed. Of the received samples, 1.2% of were not processed because the time from patient 
collection to laboratory receipt was more than 14 days. Outreach was associated with a lower 
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proportion of mishandled samples (16.5% vs 25.0% for usual care; P < .0001). The proportion of 
mishandled samples was lowest among patients who received the low literacy level instruction and 
a reminder call (12.8%, P < .0001). There was no significant difference in proportions of positive 
results between properly processed samples (7.5%) and improperly processed samples (6.2%) (P 
= .14).
CONCLUSION: In a prospective study of patients who were not up to date with colorectal cancer 
screening, we found that almost 20% of FIT samples were mishandled, with most patients missing 
the stool collection date. Patient outreach was associated with a lower proportion of mishandled 
samples, but there was no difference in proportions of positive results between properly and 
improperly handled samples. Our findings indicate that routine processing of undated FIT samples 
is associated with similar rates of positive results. There are limited data on test characteristics for 
FIT samples beyond the 14 days of stool acquisition. The inclusion of low literacy level 
instructions with reminder calls was associated with improved patient handling of the FIT sample. 
ClincialTrials.gov no:
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Colorectal cancer (CRC) is the second leading cause of cancer deaths in the United States.1,2 
Despite evidence that screening is effective in reducing CRC mortality,3 screening is 
underutilized in the general population.4,5 Screening options include noninvasive methods 
such as the fecal immunochemical test (FIT).
The safety-net health system is an integrated network comprised of publicly subsidized 
health services to the low-income population. Within safety-net health systems, FIT has 
been a preferred option for population-level screening.5 However, low-income, recent 
immigrants, and non–English-speaking populations who often receive care from safety-net 
health systems may experience difficulty comprehending and completing FIT using word-
based and English instructions.6–8 Despite effectiveness of FIT for population-level 
screening for CRC,2,9 screening relies on patients properly completing FIT tests for 
laboratory processing.6,10,11 Studies have examined FIT mailing to improve screening rates,
12–15
 but little has been reported on the frequency of and reasons for mishandled FIT 
specimens and the impact of FIT completion errors on the test result. Moreover, the 
performance characteristics of FIT may be altered by mishandling of FIT specimens, such 
that positivity rates decrease with delays in processing and exposure to higher temperature.
11,16–19
Our objective was to examine the frequency of and reasons for mishandled FIT samples. To 
examine this issue, we performed a subanalysis within a randomized trial of mailed FIT 
outreach in the form of low-literacy instructions (LLI) and reminder phone calls in a large 
integrated safety-net health system. We also examined the rate of positive FIT results in 
mishandled vs properly completed samples.
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Materials and Methods
Study Setting
This study was based in the San Francisco Health Network (SFHN). SFHN is a publicly 
funded, integrated safety-net health system comprising 12 community- and hospital-based 
adult primary care clinics and 1 specialty referral center, Zuckerberg San Francisco General 
Hospital. SFHN clinics share an integrated electronic health records platform,20 a clinical 
laboratory, and 1 gastroenterology referral unit at Zuckerberg San Francisco General 
Hospital.21
Study Population
Our examination of FIT samples is nested within a randomized controlled trial of patients 
recruited from December 2015 to August, 2017. This study was approved by the University 
of California, San Francisco’s institutional review board (#14–14861; ). The parent study 
enrolled patients not up to date with colorectal cancer screening (Supplementary Appendix). 
This included men and women aged 50–75 years who had not completed a FIT within 365 
days, sigmoidoscopy within 5 years, or colonoscopy within 10 years. Patients were excluded 
from the parent clinical trial if they were homeless, had abnormal FIT but no follow-up 
colonoscopy completed, had a diagnosis of CRC or colectomy, or had limited life 
expectancy. Eligible patients were randomized from 8 participating clinics to usual care or 
outreach with mailed FIT kits. All kits were returned by mail to 1 hospital-based clinical 
laboratory. For our subanalysis of FIT samples for this manuscript, we examined data from 
the 4916 FIT samples that were returned to the laboratory. A total of 1871 were returned 
from patients assigned to usual care, and 3045 were returned from patients assigned to the 
outreach intervention.
Study Design
Patients were randomized to receive an outreach intervention which included a mailed FIT 
kit or usual care. The outreach intervention included a prompting postcard and phone call 2 
weeks before the mailed FIT kit, a low-literacy wordless FIT instruction accompanying the 
mailed FIT kit (Figure 1) or up to 2 reminder phone calls if the FIT kit was not returned after 
2 weeks, or both. Patients assigned to usual care were not mailed a FIT kit. Patients 
receiving usual care obtained their FIT kit with standard manufacturer instructions during a 
clinic visit. However, some patients (n = 503) who were assigned to the outreach arm 
received their FIT kits during an encounter with their provider preceding receipt of the FIT 
kit through the outreach intervention, despite being assigned to outreach. These patients did 
not receive a low-literacy wordless instruction, and may have only received a reminder 
phone call. All outreach intervention components were developed and tested in patient 
advisory boards.
Study Variables
Demographic information and clinical laboratory data were extracted from the electronic 
medical records (eClinicalWorks) and managed using Microsoft Access (version 2016; 
Microsoft, Redmond, WA).
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The FIT kits (Polymedco CDP, Cortlandt Manor, NY) used for usual care and outreach were 
the OC-Light (before April 2016) and the OC-Auto FIT (from April 2016 to August 2017). 
Usual care received manufacturer instructions while outreach received low-literacy wordless 
instructions. Mishandled samples were defined by absence of stool collection date on the 
FIT label, inappropriate quantity of stool, absence of buffer, improperly capped test tube, or 
test tube tampering. Among returned FIT samples, the clinical laboratory noted improperly 
handled specimen and recorded the test result if they were able to process the test. These 
notes were captured during data extraction and curated into the specific categories. Per 
manufacturer guidelines, FIT samples with stool collection dates exceeding 14 days to the 
time of receipt at the laboratory were not processed and were cancelled. Laboratory 
processing for returned FIT was based on the difference of date of clinical laboratory receipt 
and date of stool collection date being less than 14 days. FIT samples with unknown stool 
collection dates were also allowed to be processed by the clinical laboratory; however, the 
clinical laboratory inserted a note stating, “Collection date unknown. Samples may have 
exceeded 14 day stability period.” The clinical laboratory was blinded to study interventions.
Analytic Plan
Patient characteristics were described as proportions and means, and compared using chi-
square test and Student’s t test as appropriate. Patients who were included in our analyses 
had all returned the FIT kits to the laboratory. The primary outcome was the rate of 
mishandled FIT samples received by the clinical lab out of all FIT kits received in the usual 
care group compared with the outreach intervention group. To determine the effect of 
specific intervention components on the rate of mishandled FIT samples, we examined the 
subgroup of patients in the intervention group who received their FIT kit by mail and those 
that received their FIT kit during a clinic visit after being assigned to the outreach 
intervention, and compared this to usual care. Similarly, we examined the subgroup of 
patients who received the FIT kit by mail, which contained the LLI, but returned the FIT kit 
before a reminder call (RC). Last, we examined the subgroup who received the FIT kit with 
the LLI but also received the RC. These were all compared with usual care to examine the 
effect of each component of the outreach intervention. We also evaluated the rate of positive 
or abnormal FIT results among properly completed and mishandled samples and how it 
differed by outreach and usual care. Other analyses included the association of outreach with 
the frequency of mishandled FIT samples stratified by patient demographics (language, race) 
and a history of completing a prior FIT.
Statistically significant results were considered when P < .05 using a 2-tailed test. Displayed 
95% confidence intervals (CIs) were calculated by the Wald method. Stata/IC (version 15.0; 
StataCorp, College Station, TX) statistical software was used for all analyses.
All authors had access to the study data and reviewed and approved the final manuscript.
Wang et al. Page 4
Clin Gastroenterol Hepatol. Author manuscript; available in PMC 2020 August 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Results
Patient Demographics
The mean age of patients completing the FIT was 59 years, and 49% were men. The cohort 
was racially diverse, with 19% White, 24% Asian, 19% Black, and 23% Hispanic (Table 1) 
participants and 50% primary English speakers, 20% Spanish speakers, and 9% who 
identified Chinese as their primary language. The mean age and sex distribution were similar 
in the usual care and outreach groups (Table 1). Patients in the outreach group were slightly 
more likely to be white (20.0% in outreach group, 17.4% in usual care group; P = .02). 
Among the patients whose language was known, the percentage who spoke English, 
Spanish, or Chinese was similar in the usual care and outreach groups.
Mishandled FIT Samples
Of the 4916 FIT samples returned, there were 971(19.8%) mishandled samples according to 
clinical laboratory notes. Of 971 mishandled samples, 59 samples with stool collection dates 
were not processed by the clinical laboratory (1.2% of all returned kits) due to date of 
returned FIT exceeding 14 days. Overall, the vast majority of mishandled samples were due 
to missing date of stool collection (93.7%) (Table 2). Compared with usual care, the group 
receiving FIT distributed through mailed outreach had a lower frequency of mishandled 
samples (25.0% vs 16.5%, P < .0001) (Figure 2A).
Association of Outreach With Mishandled FIT Samples
To determine the association of specific outreach intervention components with the rate of 
mishandled FIT samples, we examined the subgroups of patient who received partial vs all 
components of the intervention (Figure 2B).
In the intervention group of patients (n = 503) who received the FIT kit in the clinic before 
outreach could be initiated, the frequency of mishandled FIT samples from patients who 
received neither LLI nor an RC (LLI−RC−) (n = 367) was 26.4% (95% CI, 21.7%–31.2%, P 
= .66 vs usual care); this decreased to 18.4% among patients who received only a RC (LLI
−RC+) (n = 136) (95% CI, 11.0%–25.8%, P = .061 vs LLI−RC−).
In the intervention group (n = 2542) who received the FIT kit instructions by mail, which 
was accompanied by LLI, patients could have returned the FIT kit before or following an 
RC. In the subgroup that received the LLI but returned their kit before the RC (LLI+RC−) (n 
= 1766), the frequency of mishandled FIT samples was 16.0% (95% CI, 14.3%–17.8%, P < .
0001 vs LLI−RC−). Patients who received both LLI and the RC (LLI+RC+) (n = 776) had the 
lowest rate of mishandled FIT samples at 12.8% (95% CI, 10.3%–15.3%, P < .0001 vs LLI
−RC−).
Mishandled FIT Samples and Positivity Rates
Among samples that were processed, FIT positivity rate was slightly higher for the samples 
that were mishandled than for the other FIT samples, but this difference was not statistically 
significant (7.5% vs 6.2%; P = .14). The rate of FIT positivity in mishandled FIT samples 
was similar between patients assigned to usual care and outreach (7.5% vs 7.6%; P = 0.97).
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The outreach group had a higher proportion of patients who had no prior FIT testing (26.4% 
vs 22.6%, P = .002). Patients who had no prior FIT testing had a modestly higher rate of 
mishandled FIT samples compared with patients who previously completed the test (usual 
care 28.7% vs 23.9%, P = .055; outreach 17.2% vs 16.3%, P = .58); however, the rate of 
mishandled FIT samples was higher for the usual care group both among those with and 
without prior FIT testing. FIT positivity was higher in patients who had no prior FIT testing 
(9.9% vs 5.4%, P < .0001). Among mishandled FIT samples, the FIT positivity rate in those 
with no prior FIT tests and those with prior FIT tests was 10.9% vs 6.3% (P = .02), whereas 
among appropriately handled FIT samples, the FIT positivity rate was 9.6% in those with no 
prior FIT tests and 5.1% in those with a prior FIT test (P < .0001).
Mishandled FIT Samples by Language and Race
Outreach interventions were associated with a lower rate of mishandled FIT samples across 
all language and race categories. Outreach was associated with lower frequency of 
mishandled samples among patients who identified English as their preferred language 
(27.1% vs 18.1%, P < .0001) and among non-English speakers (Spanish speaking, 20.2% vs 
13.7%, P = .014; Chinese speaking, 21.3% vs 14.5%, P = .087). Within racial and ethnic 
groups, outreach also was associated with lower frequency of mishandled samples: Whites 
(30.2% vs 17.1%, P < .0001), Blacks (35.3% vs 24.4%, P < .0001), Hispanics (21.1% vs 
12.6%, P < .0001), and Asians (18.8% vs 14.2%, P = .03).
OC-Auto and OC-Light FIT Tests
Compared with usual care, outreach was associated with lower rate of mishandled FIT 
samples for both OC-Light and OC-Auto FIT kits (33.2% vs 20.1% for OC-Light, P < .
0001; 22.9% vs 15.3% for OC-Auto, P < .0001). Comparing the 2 different FIT kits, OC-
Auto was less likely to be mishandled (24.7% vs 18.4%, P < .0001).
Discussion
As clinical laboratory practices vary and some labs discard mishandled FIT samples, 
properly completing FIT for lab processing is an important first step in stool-based 
screening.11,22–24 Minimizing patient errors when completing at home FIT is important to 
achieving maximal screening participation.7,8 To our knowledge, our study is the first to 
describe the various reasons for mishandled FIT within a safety-net population and explore 
whether LLI and phone reminders are associated with the quality of FIT handling. We show 
that mishandled FITs are common, with the vast majority due to missing stool collection 
date, which were still processed in our clinical setting. This allowed us to examine whether 
the absence of a stool collection date was associated with a lower FIT positivity rate. 
Furthermore, we show that a combination of LLI and an RC was associated with a reduction 
in the quality of handling of FIT samples by patients.
Previous literature has raised concerns over the rate of degradation of hemoglobin over time 
and by temperature leading to reduced FIT sensitivity.11,16,17,25 In our study, mishandled 
FIT samples, in the form of a missing stool collection date, were not associated with a 
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higher rate of FIT positivity. Patients who did and did not properly label the stool collection 
date may have returned their FIT kits at similar times following sample collection.
This study underscores the value of LLI and timely use of prompts and reminders to educate 
and engage patients in testing. Pictorial-based instructions increase FIT test completion and 
return rate8,26; in the same way, we show that low-literacy wordless FIT instruction was 
associated with a reduction in mishandled samples. Specifically, each component of the 
outreach intervention appeared to be valuable. Moreover, the LLI was associated with a 
lower rate of mishandled samples within each major racial and ethnic group and among 
patients who preferred non-English language.
There are several limitations of this study. First, as this was a pragmatic study, clinics were 
allowed to choose their own method to educate and instruct patients. Different clinics may 
have different practices, and the heterogeneity between clinic practices was not captured in 
this study. However, we did observe a reduction in mishandling for those enrolled in the 
outreach intervention. Second, we only analyzed the subgroup who returned FIT kits, and 
the results could be confounded by other patient characteristics. Third, there remains a 
significant proportion of patients that still do not adhere to the wordless instructions and do 
not put a date on the stool collection bottle. Qualitative approaches would be needed to 
identify the root causes. Fourth, this study was a secondary analysis. As the intervention is 
multicomponent, there could be some overlapping effect that cannot be teased apart. The 
impact of the LLI and RC might be evaluated more directly with a randomized control trial 
that randomizes each intervention component. Last, ambient temperature conditions were 
not collected for each sample. Further studies should be performed regarding the stability of 
the samples over time as there is data suggesting instability in the presence of high 
temperature.11,16–19
In conclusion, mishandled FIT samples received by the clinical laboratory are common. The 
most frequent cause is the absence of a stool collection date. There is concern for 
hemoglobin degradation with time; however, there is little evidence that positivity rates are 
altered by the absence of collection date which may reassure providers and clinical 
laboratories that FIT results are valid even when collection date is not recorded and should 
be processed. However, we remain mindful that the practice of processing undated FIT 
specimens may not be representative of individuals with false negatives from mishandled 
samples greater than 14 days of age. Hence, the routine processing of undated FIT samples 
is not associated with lower positivity rates. Further studies should be performed regarding 
the stability of the samples over time as there are data suggesting instability in the presence 
of high temperature. Our data show that low-literacy wordless instructions and reminder 
phone calls may be helpful in reducing missing information in FIT samples returned by 
mail, even among non–English-speaking and racially and ethnically diverse populations. 
Standardized materials and communication with patient feedback as used in this outreach 
initiative underscore how health systems can enhance the patient experience.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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What You Need to Know
Background
Home fecal immunochemical test (FIT) can increase colorectal cancer screening, but it is 
not clear that patients mishandle their samples. We collected data from patients randomly 
assigned to groups that received a mailed FIT with low literacy level instructions and a 
reminder call (outreach) or usual care.
Findings
Almost 20% samples were mishandled; most of these (93.7%) had not labeled the date of 
stool collection, which was still processed by the clinical laboratory. Outreach was 
associated with a lower proportion of mishandled samples. There was no significant 
difference in the rate of abnormal results between properly handled and mishandled 
samples.
Implications for patient care
We recommend routine processing of undated FIT samples and inclusion of low literacy 
level instructions with reminder calls to improve sample handling by patients.
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Figure 1. 
Low literacy wordless instruction accompanying the mailed fecal immunochemical test kit.
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Figure 2. 
Frequency of mishandled fecal immunochemical test (FIT) tests by usual care or exposure to 
different components of the intervention. (A) Compared with usual care, outreach was 
associated with decreased percentage of mishandled FIT samples returned to the clinical 
laboratory. (B) In the outreach arm, components of the study intervention were associated 
with reduced rate of mishandled FIT samples. LLI = instructions; RC = reminder call.
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Table 1.
Demographics of patients who returned FIT samples
Usual care (n = 1871) Outreach (n = 3045)
Age, y 59 59
Sex
 Male 48.8 (913) 49.8 (1517)
 Female 51.2 (958) 50.2 (1528)
Race
 White 17.4 (325) 20.0 (609)
 Black 19.1 (357) 19.0 (579)
 Hispanic 24.1 (451) 23.0 (701)
 Asian 24.7 (462) 23.4 (712)
 Other 14.7 (275) 14.6 (444)
Language
 English 39.2 (734) 57.3 (1745)
 Spanish 13.5 (252) 23.2 (707)
 Chinese 6.5 (122) 9.8 (297)
 Other/unknowna 40.8 (763) 9.7 (296)
NOTE. Values are mean or % (n).
FIT, fecal immunochemical test.
aOutreach provided an opportunity to confirm preferred language, which resulted in fewer patients grouped in other/unknown.
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Table 2.
Reasons for mishandled FIT samples
Usual care (n = 468) Outreach (n = 503)
Unknown date 94.7 (443) 92.8 (467)
Test tube tampering 0.2 (1) 0.0 (0)
Other/unknown 0.2 (1) 0.2 (1)
Cancelled (exceeding 14 days) 4.9 (23) 7.0 (36)
NOTE. Values are % (n). Inappropriate quantity of stool and absence of buffer were not observed in our study sample. Percentages are percent of 
total mishandled in usual care or outreach group.
FIT, fecal immunochemical test.
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